Recent Posts
Archives
Kazia Therapeutics CEO Dr James Garner talks with SmallCaps about what's on the horizon
![Kazianl](https://www.irdepartment.com.au/site/irmblogpropertyfile/573/Kazianl.png)
Kazia Therapeutics (ASX: KZA) CEO James Garner joins Small Caps to discuss the company’s ongoing development of its lead drug paxalisib, which recently generated positive interim data in a phase one clinical trial for treating brain metastases.